Sampre Nutritions Limited Press Release Nov 05 2025

Board Meeting outcome for standalone and consolidated unaudited financial results for the second quarter and half-year ended 30 September 2025; with issuance and allotment of 1770710 equity shares having face value of INR 5 each at an issue price of INR 42 per equity share (including a premium of INR 37 per equity share) aggregating to INR 7,43,69,820 only on preferential basis to promoters for conversion of their existing unsecured loan in the Company.